ADD-ON TOPIRAMATE FOR THE PHARMACOLOGICAL MANAGEMENT OF SCHIZOPHRENIA: A DOUBLE BLIND RANDOMIZED CLINICAL TRIAL

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MOUSAVI S.GH.; GOLCHIN SH.; AFSHAR ZANJANI HAMID; ROUHAFZA H.R.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Psychiatry and Behavioral Sciences Year:2008 | Volume:1 | Issue:2 Page(s): 16-22

Download Full-Text

View:

401

Download:

127

Cites:

Information Journal Paper

Title

ADD-ON TOPIRAMATE FOR THE PHARMACOLOGICAL MANAGEMENT OF SCHIZOPHRENIA: A DOUBLE BLIND RANDOMIZED CLINICAL TRIAL

Author(s)

MOUSAVI S.GH. | GOLCHIN SH. | AFSHAR ZANJANI HAMID | ROUHAFZA H.R. | Issue Writer Certificate

Keywords

TOPOIRAMATE

SCHIZOPHRENIA

CLINICAL TRIAL

Abstract

Objective: Glutamate antagonists including anticonvulsant topiramate have been recommended for the pharmacological management of SCHIZOPHRENIA.Methods: A randomized, double-blind, placebo controlled CLINICAL TRIAL was performed on 32 patients diagnosed with SCHIZOPHRENIA (18-45 years old). Baseline information was gathered on demographic characteristics, vital signs, height, weight, smoking habit, (past) psychiatric history, drug history and adverse effects to medication. Patients were randomly assigned to topiramate group (n=16) or placebo one (n=16). Positive and negative syndrome scale (PANSS) was administered on each patient at baseline, on days 28 and 56. Results: The mean total PANSS score in topiramate group was 96.87 (85.37-108.37) at baseline, 85.68 (74.67-96.70) on day 28 and 76.87(66.06-87.69) on day 56. These were 101.87 (90.37-113.37), 100.31 (89.29- 111.32) and 100.56 (89.74-111.37) respectively in placebo group. General linear model for repeated measure analysis showed that topiramate has lowered PANSS score significantly.Conclusion: Significant decline was also found in all three PANSS components (negative, positive and psychopathology symptoms). Topiramate can therefore be used as an effective add-on medication in treating SCHIZOPHRENIA.

Cites

No record.

References

No record.

Cite

APA: Copy

MOUSAVI, S.GH., GOLCHIN, SH., AFSHAR ZANJANI, HAMID, & ROUHAFZA, H.R.. (2008). ADD-ON TOPIRAMATE FOR THE PHARMACOLOGICAL MANAGEMENT OF SCHIZOPHRENIA: A DOUBLE BLIND RANDOMIZED CLINICAL TRIAL. IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES (IJPBS), 1(2), 16-22. SID. https://sid.ir/paper/311882/en

Vancouver: Copy

MOUSAVI S.GH., GOLCHIN SH., AFSHAR ZANJANI HAMID, ROUHAFZA H.R.. ADD-ON TOPIRAMATE FOR THE PHARMACOLOGICAL MANAGEMENT OF SCHIZOPHRENIA: A DOUBLE BLIND RANDOMIZED CLINICAL TRIAL. IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES (IJPBS)[Internet]. 2008;1(2):16-22. Available from: https://sid.ir/paper/311882/en

IEEE: Copy

S.GH. MOUSAVI, SH. GOLCHIN, HAMID AFSHAR ZANJANI, and H.R. ROUHAFZA, “ADD-ON TOPIRAMATE FOR THE PHARMACOLOGICAL MANAGEMENT OF SCHIZOPHRENIA: A DOUBLE BLIND RANDOMIZED CLINICAL TRIAL,” IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES (IJPBS), vol. 1, no. 2, pp. 16–22, 2008, [Online]. Available: https://sid.ir/paper/311882/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops